期刊文献+

2型糖尿病患者血清25(OH)D浓度及骨代谢指标水平的分析 被引量:6

Analysis of serum 25(OH)D levels and bone turnover markers in type 2 diabetes
原文传递
导出
摘要 目的观察2型糖尿病(T2DM)患者血清25-羟基维生素D[25(OH)D]、甲状旁腺素(PTH)及全端骨钙素(OC)、I型胶原氨基末端前肽(P1NP)、I型胶原氨基末端前肽(β-CTX)的变化,分析T2DM患者和非糖尿病者骨代谢指标的差异。方法选取T2DM患者166例作为糖尿病组,并按骨密度测定的T值分为骨质疏松组、骨量减少组、骨量正常组;另选健康人群62例作为正常对照组。测定两组血清25(OH)D、PTH指标及OC、P1NP和β-CTX浓度。结果糖尿病组中骨质疏松及骨量减少例数明显高于正常对照组、血25(OH)D和OC水平低于对照组;糖尿病组与正常对照组的PTH、P1NP和β-CTX水平无显著差异,但在糖尿病骨量减少组和骨质疏松组中P1NP和β-CTX水平明显增高。结论 T2DM患者存在维生素D缺乏现象,其发生骨质疏松以及骨量减少的概率明显增加。可对T2DM患者定期进行骨代谢相关检查,以便早期发现并诊断糖尿病性骨质疏松。 Objective To observe the levels changes of serum 25(OH)D,PTH,OC,P1 NP andβ-CTX in T2 DM,and to analyze the difference of bone metabolism indexes between type 2 diabetic and non-diabetic patients.Methods 166 cases with T2 DM were selected and divided into osteoporosis group,osteopenia decreased group and normal bone mass group according to T value of bone mineral density,62 healthy cases as contrast group.Serum 25(OH)D,PTH,OC,P1 NP andβ-CTX concentrations were measured.Results The cases number of osteoporosis and osteopenia decreased in diabetes were more than contrast group,and the blood 25(OH)D,OC concentrations were lower.The level of PTH,P1 NP andβ-CTX were no difference between diabetes group and contrast group,but it was significantly higher in the osteopenia decreased group and the osteoporosis group.Conclusion Vitamin D deficiency is present in patients with T2 DM,and the probability of osteoporosis and bone loss are significantly increased.Diabetic osteoporosis can be detected and diagnosed early by regular monitoring of bone metabolism in patients with T2 DM.
作者 孙春梅 李子玲 路青玉 SUN Chun-mei;LI Zi-ling;LU Qing-yu(Inner Mongolia Baotou Steel Hospital,Baotou,Inner Mongolia,014010,China)
机构地区 内蒙古包钢医院
出处 《中国冶金工业医学杂志》 2019年第3期254-255,共2页 Chinese Medical Journal of Metallurgical industry
关键词 T2DM 糖尿病性骨质疏松 25(OH)D PTH P1NP OC β-CTX Type 2 diabetes Diabetic Osteoporosis 25(OH)D PTH P1NP OC β-CTX
  • 相关文献

参考文献3

二级参考文献17

  • 1牛银玲,邵小英.糖尿病性骨质疏松[J].中国骨质疏松杂志,2007,13(2):138-140. 被引量:13
  • 2Elsa SS, Jane AC. Diabetes mellitus, bone mineral density, and fracture risk [J]. Curr Opin Endoerinol Diabetes Obes, 2008, 14: 429-435.
  • 3Huopio J, Kroger H, Honkanen R, et al. Risk factor for perimeno- pausal fractures: a prospective study [J]. Osteoporos Int, 2000, 11 (3): 219-227.
  • 4Merchant R, Udani A, Puff V, et al. Evaluation of osteopathy in thal- assemia by bone mineral densitometry and biochemical indices [J]. Indian J Pediatr, 2010, 77(9): 987-991.
  • 5Sambrook P, Cooper C. Osteoporosis [J]. Lancet, 2006, 17:2010-2018.
  • 6Delmas PD, Seeman E. Changes in bone mineral density explain lit- tle of the reduction in vertebral or nonvertebral fracture risk with an- tiresorptive therapy [J].Bone, 2004, 34: 599-604.
  • 7Somay RE, Munoz F, Garnero P, et al. Identification of osteopenic women at high risk off mcture [J]. J Bone Miner Res, 2005, 20: 1813-1819.
  • 8Wei-bo XIA,Zhong-lan ZHANG,Hong-fu WANG,Xun-wu MENG,Ying ZHANG,Guo-ying ZHU,Xiao-ping XING,Jian-li LIU,Li-hua WANG,Yan JIANG,Shi-fang WENG,Tao XU,Ying-ying HU,Wei YU,Jun-ping TIAN.The efficacy and safety of calcitriol and/or Caltrate D in elderly Chinese women with low bone mass[J].Acta Pharmacologica Sinica,2009,30(3):372-378. 被引量:11
  • 9喻晶,余学锋.骨代谢标志物和骨矿密度在骨质疏松症中的应用[J].临床内科杂志,2009,26(3):155-157. 被引量:14
  • 10徐琳,金晖,孙子林.糖尿病与脆性骨折[J].中国骨质疏松杂志,2009,15(5):382-385. 被引量:27

共引文献30

同被引文献66

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部